SUBSCRIBERS

Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth

Megan Cheah
Vivienne Tay
Published Mon, Feb 26, 2024 · 08:34 AM
    • The group attributes the weaker performance to the discontinuation of Covid-19-related activities in FY2023.
    • The group attributes the weaker performance to the discontinuation of Covid-19-related activities in FY2023. PHOTO: LIM YAOHUI, ST

    RAFFLES Medical Group posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.

    The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).

    The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.